•Executive Summary
oMarket Overview
•Market Landscape
oMarket ecosystem
oValue chain analysis
•Market Sizing
oMarket definition
oMarket segment analysis
oMarket size 2019
oMarket outlook: Forecast for 2019-2024
•Five Forces Analysis
oFive Forces Summary
oBargaining power of buyers
oBargaining power of suppliers
oThreat of new entrants
oThreat of substitutes
oThreat of rivalry
oMarket condition
•Market Segmentation by Application
oMarket segments
oComparison by Application
oInfectious diseases - Market size and forecast 2019-2024
oOncology - Market size and forecast 2019-2024
oOthers - Market size and forecast 2019-2024
oMarket opportunity by Application
•Customer landscape
oOverview
•Geographic Landscape
oGeographic segmentation
oGeographic comparison
oNorth America - Market size and forecast 2019-2024
oEurope - Market size and forecast 2019-2024
oAsia - Market size and forecast 2019-2024
oROW - Market size and forecast 2019-2024
oKey leading countries
oMarket opportunity by geography
oVolume driver - Demand led growth
oVolume driver - Supply led growth
oVolume driver - External factors
oMarket challenges
oMarket trends
•Vendor Landscape
oOverview
oLandscape disruption
•Vendor Analysis
oVendors covered
oMarket positioning of vendors
oAbbott Laboratories
obioMérieux SA
oBio-Rad Laboratories Inc.
oCredo Biomedical Pte. Ltd.
oDanaher Corp.
oF. Hoffmann-La Roche Ltd.
oMeridian Bioscience Inc.
oOxford Nanopore Technologies Ltd.
oQIAGEN N.V.
oQuantuMDx Group Ltd.
•Appendix
oScope of the report
oCurrency conversion rates for US$
oResearch methodology
oList of abbreviations

Exhibit
•1: Key Finding 1
•2: Key Finding 2
•3: Key Finding 3
•4: Key Finding 5
•5: Key Finding 6
•6: Key Finding 7
•7: Key Finding 8
•8: Parent market
•9: Market characteristics
•10: Offerings of vendors included in the market definition
•11: Market segments
•12: Global - Market size and forecast 2019 - 2024 ($ million)
•13: Global market: Year-over-year growth 2019 - 2024 (%)
•14: Five forces analysis 2019 & 2024
•15: Bargaining power of buyers
•16: Bargaining power of suppliers
•17: Threat of new entrants
•18: Threat of substitutes
•19: Threat of rivalry
•20: Market condition - Five forces 2019
•21: Application - Market share 2019-2024 (%)
•22: Comparison by Application
•23: Infectious diseases - Market size and forecast 2019-2024 ($ million)
•24: Infectious diseases - Year-over-year growth 2019-2024 (%)
•25: Oncology - Market size and forecast 2019-2024 ($ million)
•26: Oncology - Year-over-year growth 2019-2024 (%)
•27: Others - Market size and forecast 2019-2024 ($ million)
•28: Others - Year-over-year growth 2019-2024 (%)
•29: Market opportunity by Application
•30: Customer landscape
•31: Market share by geography 2019-2024 (%)
•32: Geographic comparison
•33: North America - Market size and forecast 2019-2024 ($ million)
•34: North America - Year-over-year growth 2019-2024 (%)
•35: Europe - Market size and forecast 2019-2024 ($ million)
•36: Europe - Year-over-year growth 2019-2024 (%)
•37: Asia - Market size and forecast 2019-2024 ($ million)
•38: Asia - Year-over-year growth 2019-2024 (%)
•39: ROW - Market size and forecast 2019-2024 ($ million)
•40: ROW - Year-over-year growth 2019-2024 (%)
•41: Key leading countries
•42: Market opportunity by geography ($ million)
•43: Impact of drivers and challenges
•44: Vendor landscape
•45: Landscape disruption
•46: Industry risks
•47: Vendors covered
•48: Market positioning of vendors
•49: Abbott Laboratories - Overview
•50: Abbott Laboratories - Business segments
•51: Abbott Laboratories - Key offerings
•52: Abbott Laboratories - Key customers
•53: Abbott Laboratories - Segment focus
•54: bioMérieux SA - Overview
•55: bioMérieux SA - Business segments
•56: bioMérieux SA - Key offerings
•57: bioMérieux SA - Key customers
•58: bioMérieux SA - Segment focus
•59: Bio-Rad Laboratories Inc. - Overview
•60: Bio-Rad Laboratories Inc. - Business segments
•61: Bio-Rad Laboratories Inc. - Key offerings
•62: Bio-Rad Laboratories Inc. - Key customers
•63: Bio-Rad Laboratories Inc. - Segment focus
•64: Credo Biomedical Pte. Ltd. - Overview
•65: Credo Biomedical Pte. Ltd. - Product and service
•66: Credo Biomedical Pte. Ltd. - Key offerings
•67: Credo Biomedical Pte. Ltd. - Key customers
•68: Credo Biomedical Pte. Ltd. - Segment focus
•69: Danaher Corp. - Overview
•70: Danaher Corp. - Business segments
•71: Danaher Corp. - Key offerings
•72: Danaher Corp. - Key customers
•73: Danaher Corp. - Segment focus
•74: F. Hoffmann-La Roche Ltd. - Overview
•75: F. Hoffmann-La Roche Ltd. - Business segments
•76: F. Hoffmann-La Roche Ltd. - Key offerings
•77: F. Hoffmann-La Roche Ltd. - Key customers
•78: F. Hoffmann-La Roche Ltd. - Segment focus
•79: Meridian Bioscience Inc. - Overview
•80: Meridian Bioscience Inc. - Business segments
•81: Meridian Bioscience Inc. - Key offerings
•82: Meridian Bioscience Inc. - Key customers
•83: Meridian Bioscience Inc. - Segment focus
•84: Oxford Nanopore Technologies Ltd. - Overview
•85: Oxford Nanopore Technologies Ltd. - Product and service
•86: Oxford Nanopore Technologies Ltd. - Key offerings
•87: Oxford Nanopore Technologies Ltd. - Key customers
•88: Oxford Nanopore Technologies Ltd. - Segment focus
•89: QIAGEN N.V. - Overview
•90: QIAGEN N.V. - Business segments
•91: QIAGEN N.V. - Key offerings
•92: QIAGEN N.V. - Key customers
•93: QIAGEN N.V. - Segment focus
•94: QuantuMDx Group Ltd. - Overview
•95: QuantuMDx Group Ltd. - Product and service
•96: QuantuMDx Group Ltd. - Key offerings
•97: QuantuMDx Group Ltd. - Key customers
•98: QuantuMDx Group Ltd. - Segment focus
•99: Currency conversion rates for US$
•100: Research Methodology
•101: Validation techniques employed for market sizing
•102: Information sources
•103: List of abbreviations

Companies Mentioned
• Abbott Laboratories
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Credo Biomedical Pte. Ltd.
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• Meridian Bioscience Inc.
• Oxford Nanopore Technologies Ltd.
• QIAGEN N.V.
• QuantuMDx Group Ltd.